Agency Information Collection Activities; Proposed Collection; Comment Request; Medicated Feed Mill License Application, 94740-94742 [2024-28036]
Download as PDF
94740
Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices
III. Electronic Access
Persons with access to the internet
may obtain the guidance at https://
www.fda.gov/drugs/guidancecompliance-regulatory-information/
guidances-drugs, https://www.fda.gov/
vaccines-blood-biologics/guidancecompliance-regulatory-informationbiologics/biologics-guidances, https://
www.fda.gov/medical-devices/deviceadvice-comprehensive-regulatoryassistance/guidance-documentsmedical-devices-and-radiation-emittingproducts, https://www.fda.gov/
regulatory-information/search-fdaguidance-documents, or https://
www.regulations.gov.
Dated: November 19, 2024.
P. Ritu Nalubola,
Associate Commissioner for Policy.
[FR Doc. 2024–28033 Filed 11–27–24; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2024–N–4687]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Medicated Feed
Mill License Application
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA, Agency, or we) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the information
collection provisions of medicated feed
mill license reporting.
DATES: Either electronic or written
comments on the collection of
information must be submitted by
January 28, 2025.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. The https://
www.regulations.gov electronic filing
system will accept comments until
11:59 p.m. Eastern Time at the end of
January 28, 2025. Comments received by
khammond on DSK9W7S144PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
21:22 Nov 27, 2024
Jkt 265001
mail/hand delivery/courier (for written/
paper submissions) will be considered
timely if they are received on or before
that date.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2024–N–4687 for ‘‘Agency Information
Collection Activities; Proposed
Collection; Comment Request;
Medicated Feed Mill License
Application.’’ Received comments,
those filed in a timely manner (see
ADDRESSES), will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
JonnaLynn Capezzuto, Office of
Operations, Food and Drug
Administration, Three White Flint
North, 10A–12M, 11601 Landsdown St.,
North Bethesda, MD 20852, 301–796–
3794, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3521), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
E:\FR\FM\29NON1.SGM
29NON1
94741
Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
Medicated Feed Mill License
Application—21 CFR Part 515
OMB Control Number 0910–0337—
Extension
This information collection helps
support implementation of statutory and
regulatory provisions related to
medicated animal feed mill licensing.
Feed manufacturers that seek to
manufacture a Type B or Type C
medicated feed using Category II, Type
A medicated articles or manufacture
certain liquid and free-choice feed using
Category I, Type A medicated articles
that must follow proprietary formulas or
specifications, are required to obtain a
facility license under section 512 of the
Federal Food, Drug, and Cosmetic Act
(FD&C Act) (21 U.S.C. 360b). Our
regulations in 21 CFR part 515 establish
the procedures associated with applying
for a facility license. We require that a
manufacturer seeking a facility license
submit a completed medicated feed mill
license application using Form FDA
3448 (21 CFR 515.10(b)). This form may
be submitted via U.S. mail or
electronically to a dedicated email
address, MedicatedFeedsTeamMail@
fda.hhs.gov. We use the information
submitted to establish that the applicant
has made the certifications required by
section 512 of the FD&C Act, to register
the mill, and to schedule a preapproval
inspection. Form FDA 3448 may be
accessed on our website at: https://
www.fda.gov/about-fda/reportsmanuals-forms/forms.
We require the submission of a
supplemental medicated feed mill
license application for a change in
facility ownership or a change in facility
address (§ 515.11(b) (21 CFR 515.11(b))).
If a licensed facility is no longer
manufacturing medicated animal feed
under § 515.23 (21 CFR 515.23), a
manufacturer may request voluntary
revocation of a medicated feed mill
license. An applicant also has the right
to file a request for hearing under
§ 515.30(c) (21 CFR 515.30(c)) to give
reasons why a medicated feed mill
license should not be refused or
revoked.
Under § 510.305 (21 CFR 510.305), we
require each applicant to maintain in a
single accessible location: (a) A copy of
the approved medicated feed mill
license (Form FDA 3448) on the
premises of the manufacturing
establishment; and (b) approved or
index listed labeling for each Type B
and/or Type C feed being manufactured
on the premises of the manufacturing
establishment or the facility where the
feed labels are generated.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
515.10(b), 515.11(b); Medicated Feed Mill License
Application and Supplemental Applications using
Form FDA 3448 ....................................................
515.23; Voluntary Revocation of Medicated Feed
Mill License ...........................................................
515.30; Filing a Request for a Hearing on Medicated Feed Mill License .......................................
Total ..................................................................
1 There
Number of
responses per
respondent
Number of
respondents
21 CFR Section; activity
Total annual
responses
Average burden per
response
Total
hours
34
1
34
0.25 (15 minutes)
8.5
14
1
14
0.25 (15 minutes)
3.5
1
1
1
4
4
........................
........................
49
........................................
16
are no capital costs or operating and maintenance costs associated with this collection of information.
We estimate that respondents will
spend 15 minutes to assemble the
necessary information, prepare, and
submit an application for a feed mill
license or revocation of a feed mill
license. We estimate that respondents
will spend 4 hours to prepare their
request for a hearing.
TABLE 2—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
Number of
recordkeepers
khammond on DSK9W7S144PROD with NOTICES
21 CFR Part; activity
510.305; Maintenance of Records for Approved Labeling for Each ‘‘Type B’’ and ‘‘Type C’’ Feed.
1 There
Number of
records per
recordkeeper
779
1
Total annual
records
Average burden per
recordkeeping
779
Total
hours
0.03 (2 minutes) .......
are no capital costs or operating and maintenance costs associated with this collection of information.
We base our estimates on our recent
experience with the existing medicated
VerDate Sep<11>2014
21:22 Nov 27, 2024
Jkt 265001
feed mill license application process.
Our estimated burden for the
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
information collection reflects an
overall increase of 2.5 hours. We
E:\FR\FM\29NON1.SGM
29NON1
23
94742
Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices
attribute this adjustment to a slight
increase in the overall number of
submissions we received over the last
few years.
Dated: November 19, 2024.
P. Ritu Nalubola,
Associate Commissioner for Policy.
[FR Doc. 2024–28036 Filed 11–27–24; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Notice of Availability of Final Health
Center Program Policy Guidance
Regarding Services To Support
Transitions in Care for JusticeInvolved Individuals Reentering the
Community
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Final notice.
AGENCY:
The final Health Center
Program Policy Guidance Regarding
Services to Support Transitions in Care
for Justice-Involved Individuals
Reentering the Community Policy
Information Notice (JI–R PIN) has been
developed to assist health centers who
choose to provide certain primary
health care services to support the
transition of JI–R individuals from the
carceral setting back into the
community setting.
DATES: This Final JI–R PIN is effective
on the date of publication of this notice.
FOR FURTHER INFORMATION CONTACT: For
questions regarding this notice, use the
HRSA Bureau of Primary Health Care
Contact Form: https://hrsa.force.com/
support/s/ or call Jennifer Joseph,
Director, Office of Policy and Program
Development, Bureau of Primary Health
Care, HRSA, at 301–594–4300.
SUPPLEMENTARY INFORMATION: HRSA
provides grants to eligible applicants
under section 330 of the Public Health
Service Act, as amended (42 U.S.C.
254b), to support the delivery of
preventive and primary care services to
the nation’s underserved individuals
and families. HRSA also certifies
eligible applicants under the Health
Center Look-Alike Program (see sections
1861(aa)(4)(B) and 1905(l)(2)(B) of the
Social Security Act). Look-alikes do not
receive Health Center Program funding
but must meet the Health Center
Program statutory and regulatory
requirements. Health centers are local
organizations that provide
khammond on DSK9W7S144PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
21:22 Nov 27, 2024
Jkt 265001
comprehensive, high-quality primary
health care services tailored to their
communities regardless of their
patients’ ability to pay. Nearly 1,400
Health Center Program-funded health
centers and more than 100 Health
Center Program look-alike organizations
operate more than 16,100 service
delivery sites that provide care to more
than 32 million patients in every U.S.
state, the District of Columbia, Puerto
Rico, the U.S. Virgin Islands, and the
Pacific Basin. Note that for the purposes
of this document, the term ‘‘health
center’’ refers to entities that receive a
federal award under section 330 of the
Public Health Service Act, as well as
subrecipients and organizations
designated as look-alikes, unless
otherwise stated.
This final JI–R PIN establishes policy
for all health centers that apply for and
receive a federal award under the Health
Center Program, as authorized by
section 330 of the Public Health Service
(PHS) Act (including sections 330(e),
(g), (h), and (i)), as well as section 330
subrecipient organizations and Health
Center Program look-alikes. This final
JI–R PIN is intended to support health
centers in providing certain health
services—delivered under the exclusive
control and authority of the health
center—to support the transition of JI–
R individuals from the carceral setting
back into the community setting. The
services the health center provides are
limited to services that support reentry.
A health center may not take on or
replace the provision of any other health
care services the carceral authority
provides to those who are incarcerated
or detained.
HRSA released a draft of the JI–R PIN
for a 60-day public comment period.
HRSA revised the JI–R PIN in response
to comments and posted a summary of
comments and HRSA’s responses at
https://bphc.hrsa.gov/sites/default/files/
bphc/compliance/pin-2024-05comments-summary.pdf.
Organizations receiving Health Center
Program federal awards, including
subrecipients, and organizations
designated as Health Center Program
look-alikes, continue to be subject to all
requirements stated in Notices of
Funding Opportunity, Notices of
Award, Look-Alike Initial Designation
and Redesignation Instructions, Notices
of Look-Alike Designation, as well as
other applicable laws, regulations, and
policies. Organizations are also subject
to the distinct statutory, regulatory, and
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
policy requirements of other federal
programs in which they participate.
Carole Johnson,
Administrator.
[FR Doc. 2024–27903 Filed 11–27–24; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Federal Financial Participation in State
Assistance Expenditures; Federal
Matching Shares for Medicaid, the
Children’s Health Insurance Program,
and Aid to Needy Aged, Blind, or
Disabled Persons for October 1, 2025,
Through September 30, 2026
Office of the Secretary, HHS.
ACTION: Notice.
AGENCY:
The Federal Medical
Assistance Percentages (FMAP),
Enhanced Federal Medical Assistance
Percentages (eFMAP), and disasterrecovery FMAP adjustments for fiscal
year 2026 have been calculated
pursuant to the Social Security Act (the
Act). These percentages will be effective
from October 1, 2025, through
September 30, 2026. This notice
announces the calculated FMAP rates,
in accordance with the Act, that the U.S.
Department of Health and Human
Services (HHS) will use in determining
the amount of Federal matching for state
medical assistance (Medicaid),
Temporary Assistance for Needy
Families (TANF) Contingency Funds,
Child Support collections, Child Care
Mandatory and Matching Funds of the
Child Care and Development Fund,
Title IV–E Foster Care Maintenance
payments, Adoption Assistance
payments and Kinship Guardianship
Assistance payments, and the eFMAP
rates for the Children’s Health Insurance
Program (CHIP) expenditures. Table 1
gives figures for each of the 50 states,
the District of Columbia, Puerto Rico,
the Virgin Islands, Guam, American
Samoa, and the Commonwealth of the
Northern Mariana Islands. This notice
reminds states of adjustments available
for states meeting requirements for
disproportionate employer pension or
insurance fund contributions and
adjustments for disaster recovery. Based
on the criteria for a qualifying state, one
state meets the requirements for an
adjustment for disaster recovery.
DATES: The percentages listed in Table
1 will be effective for each of the four
quarter-year periods beginning October
1, 2025, and ending September 30, 2026.
SUMMARY:
E:\FR\FM\29NON1.SGM
29NON1
Agencies
[Federal Register Volume 89, Number 230 (Friday, November 29, 2024)]
[Notices]
[Pages 94740-94742]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28036]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2024-N-4687]
Agency Information Collection Activities; Proposed Collection;
Comment Request; Medicated Feed Mill License Application
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA, Agency, or we) is
announcing an opportunity for public comment on the proposed collection
of certain information by the Agency. Under the Paperwork Reduction Act
of 1995 (PRA), Federal Agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments on the information collection
provisions of medicated feed mill license reporting.
DATES: Either electronic or written comments on the collection of
information must be submitted by January 28, 2025.
ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. The https://www.regulations.gov electronic filing system will accept comments until
11:59 p.m. Eastern Time at the end of January 28, 2025. Comments
received by mail/hand delivery/courier (for written/paper submissions)
will be considered timely if they are received on or before that date.
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2024-N-4687 for ``Agency Information Collection Activities;
Proposed Collection; Comment Request; Medicated Feed Mill License
Application.'' Received comments, those filed in a timely manner (see
ADDRESSES), will be placed in the docket and, except for those
submitted as ``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday, 240-402-7500.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.
FOR FURTHER INFORMATION CONTACT: JonnaLynn Capezzuto, Office of
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-3794,
[email protected].
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3521), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each
[[Page 94741]]
proposed collection of information, including each proposed extension
of an existing collection of information, before submitting the
collection to OMB for approval. To comply with this requirement, FDA is
publishing notice of the proposed collection of information set forth
in this document.
With respect to the following collection of information, FDA
invites comments on these topics: (1) whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
Medicated Feed Mill License Application--21 CFR Part 515
OMB Control Number 0910-0337--Extension
This information collection helps support implementation of
statutory and regulatory provisions related to medicated animal feed
mill licensing. Feed manufacturers that seek to manufacture a Type B or
Type C medicated feed using Category II, Type A medicated articles or
manufacture certain liquid and free-choice feed using Category I, Type
A medicated articles that must follow proprietary formulas or
specifications, are required to obtain a facility license under section
512 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C.
360b). Our regulations in 21 CFR part 515 establish the procedures
associated with applying for a facility license. We require that a
manufacturer seeking a facility license submit a completed medicated
feed mill license application using Form FDA 3448 (21 CFR 515.10(b)).
This form may be submitted via U.S. mail or electronically to a
dedicated email address, [email protected]. We use the
information submitted to establish that the applicant has made the
certifications required by section 512 of the FD&C Act, to register the
mill, and to schedule a preapproval inspection. Form FDA 3448 may be
accessed on our website at: https://www.fda.gov/about-fda/reports-manuals-forms/forms.
We require the submission of a supplemental medicated feed mill
license application for a change in facility ownership or a change in
facility address (Sec. 515.11(b) (21 CFR 515.11(b))). If a licensed
facility is no longer manufacturing medicated animal feed under Sec.
515.23 (21 CFR 515.23), a manufacturer may request voluntary revocation
of a medicated feed mill license. An applicant also has the right to
file a request for hearing under Sec. 515.30(c) (21 CFR 515.30(c)) to
give reasons why a medicated feed mill license should not be refused or
revoked.
Under Sec. 510.305 (21 CFR 510.305), we require each applicant to
maintain in a single accessible location: (a) A copy of the approved
medicated feed mill license (Form FDA 3448) on the premises of the
manufacturing establishment; and (b) approved or index listed labeling
for each Type B and/or Type C feed being manufactured on the premises
of the manufacturing establishment or the facility where the feed
labels are generated.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
21 CFR Section; activity Number of responses per Total annual Average burden per Total hours
respondents respondent responses response
--------------------------------------------------------------------------------------------------------------------------------------------------------
515.10(b), 515.11(b); Medicated Feed Mill License Application and 34 1 34 0.25 (15 minutes) 8.5
Supplemental Applications using Form FDA 3448....................
515.23; Voluntary Revocation of Medicated Feed Mill License....... 14 1 14 0.25 (15 minutes) 3.5
515.30; Filing a Request for a Hearing on Medicated Feed Mill 1 1 1 4 4
License..........................................................
-------------------------------------------------------------------------------------
Total......................................................... .............. .............. 49 ....................... 16
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
We estimate that respondents will spend 15 minutes to assemble the
necessary information, prepare, and submit an application for a feed
mill license or revocation of a feed mill license. We estimate that
respondents will spend 4 hours to prepare their request for a hearing.
Table 2--Estimated Annual Recordkeeping Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of
21 CFR Part; activity Number of records per Total annual Average burden per Total hours
recordkeepers recordkeeper records recordkeeping
----------------------------------------------------------------------------------------------------------------
510.305; Maintenance of Records 779 1 779 0.03 (2 minutes).. 23
for Approved Labeling for Each
``Type B'' and ``Type C'' Feed.
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
We base our estimates on our recent experience with the existing
medicated feed mill license application process. Our estimated burden
for the information collection reflects an overall increase of 2.5
hours. We
[[Page 94742]]
attribute this adjustment to a slight increase in the overall number of
submissions we received over the last few years.
Dated: November 19, 2024.
P. Ritu Nalubola,
Associate Commissioner for Policy.
[FR Doc. 2024-28036 Filed 11-27-24; 8:45 am]
BILLING CODE 4164-01-P